Hence, we designed a new strategy of CAR by introducing a IL-23 mAb either by duo-CAR or by linking to PSMA-CAR, in purpose of capturing the secreted IL23 by tumor cells or excited in the tumor environment. The gene discussed is FOLH1; the disease is neoplasm.